Blog
RSS FeedPosted by Michael Wonder on 01 Mar 2024
More rare conditions considered for newborn bloodspot screening and new treatment option for spinal muscular atrophy
29 February 2024 - On Rare Disease Day, the Albanese Government has announced two more rare genetic conditions have been ...
Posted by Michael Wonder on 22 Feb 2024
Terminally ill patients despair amid price war over CAR-T cancer therapy
22 February 2024 - Australia risks “being pushed to the back of the queue” of countries to gain access to ...
Posted by Michael Wonder on 10 Nov 2022
MSAC can't find a place for Carvykti
10 November 2022 - The outcome from Janssen's application requesting the public funding of ciltacabtagene autoleucel for the treatment of ...
Posted by Michael Wonder on 20 Oct 2022
MSAC recommends targeted carrier testing of certain ethic people for severe monogenic conditions
20 October 2022 - An 'eventful' week for Jewish people in Australia. ...
Posted by Michael Wonder on 19 Oct 2022
MSAC publishes outcome for Mackenzie's mission
19 October 2022 - Mackenzie’s Mission is a research study providing reproductive genetic carrier screening to up to 10,000 couples across ...
Posted by Michael Wonder on 18 Oct 2022
MSAC finally recommends genomic testing for certain women with breast cancer
18 October 2022 - A third application from Mryriad Genetics seeking the MBS listing of its gene expression profiling test ...
Posted by Michael Wonder on 13 Oct 2022
Expert advice on lung cancer screening
13 October 2022 - The Australian Government has received advice regarding a national lung cancer screening program from the independent Medical ...
Posted by Michael Wonder on 16 Apr 2019
Federal Government takes first major step in adopting new wave of personalised medicine for Australian patients
16 April 2019 - Medicines Australia welcomes the Government’s investment in new technology with Kymriah (tisagenlecleucel) CAR-T (Chimeric Antigen Receptor ...
Posted by Michael Wonder on 07 Jan 2018
Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers
4 January 2018 - This study evaluated the cost-effectiveness of BRCA testing in Australian women with breast cancer, and cascade ...
Posted by Michael Wonder on 01 Dec 2017
New cervical cancer test is great news for Australian women
1 December 2017 - Australian women will benefit from a new and more effective screening test for cervical cancer — it’s ...
Posted by Michael Wonder on 04 Oct 2017
Funding rejected for breast cancer testing
5 October 2017 - Globally recognised technology that could spare thousands of Australian breast cancer patients from unnecessary chemotherapy will ...